[Functional role for GABA transporters in the CNS].
Masayuki
M
Hiramatsu
D000818:Animals; D001921:Brain / Q000378:metabolism; D001892:Camphanes / Q000494:pharmacology / Q000627:therapeutic use; D002227:Carbazoles / Q000494:pharmacology / Q000627:therapeutic use; D002352:Carrier Proteins / Q000378:metabolism / Q000502:physiology; D002493:Central Nervous System Diseases / Q000188:drug therapy* / Q000235:genetics; D055808:Drug Discovery; D050485:GABA Plasma Membrane Transport Proteins / Q000378:metabolism / Q000502:physiology*; D058805:GABA Uptake Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007555:Isoxazoles / Q000494:pharmacology / Q000627:therapeutic use; D001523:Mental Disorders / Q000188:drug therapy* / Q000235:genetics; D058990:Molecular Targeted Therapy; D009557:Nipecotic Acids / Q000494:pharmacology / Q000627:therapeutic use; D010880:Piperidines / Q000494:pharmacology / Q000627:therapeutic use; D000078308:Tiagabine
D001892:Camphanes; D002227:Carbazoles; D002352:Carrier Proteins; C510806:EF1502; D050485:GABA Plasma Membrane Transport Proteins; D058805:GABA Uptake Inhibitors; D007555:Isoxazoles; C108938:NNC 05-2045; D009557:Nipecotic Acids; D010880:Piperidines; C072207:betaine plasma membrane transport proteins; C060555:deramciclane; D000078308:Tiagabine